U.S. News
CoreWeave beats on revenue and lifts guidance, easing AI slowdown concerns
CoreWeave’s stock has been hammered heading into the neocloud’s Q3 earnings report.
Mississippi Senate: Scott Colom extends tight lead over Hyde-Smith as ballot deadlines hit
Tuesday was the deadline for provisional ballots to be resolved in Mississippi, and the deadline for the receipt of mail-in absentee ballots.
Rep. Jim Jordan, Sen. John Thune elected GOP leaders in Congress
House Speaker Mike Johnson, R-La., announced the day after Election Day he would not run for minority leader in the 120th Congress.
I am a doc for testing charts
I am a testing doc for rendering charts
House Oversight calls on DOJ to interview key Epstein witnesses, says govt. ‘failed’ survivors
“The federal government has failed the survivors of Jeffrey Epstein and Ghislaine Maxwell’s horrific crimes for decades,” Rep. James Comer, R-Ky., said.
Rivian CEO says new R2 SUV, autonomy make 2027 an ‘inflection year’ as EV maker marks five years since IPO
Rivian CEO RJ Scaringe says 2027 will be an “inflection year” as the EV maker scales R2 and invests in autonomy.
Consumer prices rose 0.4% in October, more than expected, complicating Fed’s inflation fight
The report comes at a critical juncture for the Federal Reserve as it considers its next move regarding interest rates.
Amazon’s Ring unveils flying drone and robot to patrol homes and businesses
Amazon’s $250 Ring Drone Cam flies from room to room to investigate suspicious activity, and can capture footage at night.
Bilt bets on local businesses, hospitality and major sports franchises, expanding beyond residential rewards
Bilt is announcing the launch of two new platforms designed to help local businesses and event venues attract customers and build loyalty.
Nvidia sells off for second day in fallout from Jensen Huang’s affair with alleged spy
Investors continue to weigh the potential fallout from CEO Jensen Huang’s affair with an alleged Chinese spy.
Fed Governor Waller sees December hike likely, opens door to possible half-point increase
The policymaker said he “is leaning toward” a rate increase in December and could support a half-point hike depending on inflation data.
FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound
The agency has found evidence of a potential increased risk of a rare eye condition linked to the use of GLP-1 drugs used for weight management and diabetes.
World News
Politics
Accidents
Celebrity Dirt
